Page last updated: 2024-08-25

rosiglitazone and Cardiac Output, Low

rosiglitazone has been researched along with Cardiac Output, Low in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Biery, JC; Goins, JA; Lee, TA; Marceille, JR; Soni, R	1
Dargie, HJ; Hildebrandt, PR; McMorn, SO; McMurray, JJ; Riegger, GA; Roberts, JN; Wilding, JP; Zambanini, A	1
Furberg, CD; Loke, YK; Singh, S	1
D'Arrigo, T	1

Reviews

1 review(s) available for rosiglitazone and Cardiac Output, Low

Article	Year
Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis. JAMA, 2007, Sep-12, Volume: 298, Issue:10 Topics: Cardiac Output, Low; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Myocardial Infarction; Randomized Controlled Trials as Topic; Risk; Rosiglitazone; Thiazolidinediones	2007

Trials

1 trial(s) available for rosiglitazone and Cardiac Output, Low

Article	Year
A randomized, placebo-controlled trial assessing the effects of rosiglitazone on echocardiographic function and cardiac status in type 2 diabetic patients with New York Heart Association Functional Class I or II Heart Failure. Journal of the American College of Cardiology, 2007, Apr-24, Volume: 49, Issue:16 Topics: Aged; Cardiac Output, Low; Diabetes Mellitus, Type 2; Double-Blind Method; Echocardiography; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Rosiglitazone; Thiazolidinediones; Ventricular Function, Left; Water-Electrolyte Balance	2007

Article

Year

A randomized, placebo-controlled trial assessing the effects of rosiglitazone on echocardiographic function and cardiac status in type 2 diabetic patients with New York Heart Association Functional Class I or II Heart Failure.

Journal of the American College of Cardiology, 2007, Apr-24, Volume: 49, Issue:16

Topics: Aged; Cardiac Output, Low; Diabetes Mellitus, Type 2; Double-Blind Method; Echocardiography; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Rosiglitazone; Thiazolidinediones; Ventricular Function, Left; Water-Electrolyte Balance

2007

Other Studies

2 other study(ies) available for rosiglitazone and Cardiac Output, Low

Article	Year
Chronic heart failure-related interventions after starting rosiglitazone in patients receiving insulin. Pharmacotherapy, 2004, Volume: 24, Issue:10 Topics: Adolescent; Adult; Aged; Cardiac Output, Low; Chronic Disease; Cohort Studies; Diabetes Mellitus, Type 2; Drug Synergism; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Retrospective Studies; Rosiglitazone; Thiazolidinediones	2004
Avandia update. Committee urges caution on heart risks. Diabetes forecast, 2007, Volume: 60, Issue:10 Topics: Advisory Committees; Cardiac Output, Low; Contraindications; Diabetes Mellitus, Type 2; Humans; Risk Assessment; Rosiglitazone; Thiazolidinediones; United States	2007

Article

Year

Chronic heart failure-related interventions after starting rosiglitazone in patients receiving insulin.

Pharmacotherapy, 2004, Volume: 24, Issue:10

Topics: Adolescent; Adult; Aged; Cardiac Output, Low; Chronic Disease; Cohort Studies; Diabetes Mellitus, Type 2; Drug Synergism; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Retrospective Studies; Rosiglitazone; Thiazolidinediones

2004

Avandia update. Committee urges caution on heart risks.

Diabetes forecast, 2007, Volume: 60, Issue:10

Topics: Advisory Committees; Cardiac Output, Low; Contraindications; Diabetes Mellitus, Type 2; Humans; Risk Assessment; Rosiglitazone; Thiazolidinediones; United States

2007